---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-001070"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:17:00.817109+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $597K in registered PIPE, issuing ~1.13M shares and warrants

## Summary
- Issued 1,129,996 shares at $0.52876/share and warrants for 564,998 shares at $0.46626.
- Gross proceeds of $597,496.72; warrants exercisable 6 months out, expire in 5.5 years.
- Laidlaw receives warrant for 84,750 shares as compensation for introducing the PIPE.
- Securities sold under Section 4(a)(2) & Regulation D; reliance on exemption from registration.

## SEC filing metadata
- accession: 0001185185-23-001070
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/0001185185-23-001070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/biosig20231013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-001070
- JSON: https://secwatch.observer/filing/0001185185-23-001070.json
- Plain text: https://secwatch.observer/filing/0001185185-23-001070.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $597,496.72 (effective 2023-10-12).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $597,496.72
  - Effective: 2023-10-12
  source text: On October 12, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,129,996 shares (the “Shares”) of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/0001185185-23-001070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.